Series A Financing
Advised R3 Vascular on the foregoing transaction
Equity investment in Scioto Biosciences’ Series B and Strategic Collaboration with Scioto Biosciences
Advised Genome & Company on the foregoing transaction
Series B Financing
Advised Adicet Bio on the foregoing transaction
Series A Financing
Advised bioClarity on the foregoing transaction
Series B Financing
Advised Oncologie on the foregoing transaction
Strategic Collaboration & Global Licensing Agreement
Advised BridgeBio Therapeutics on the foregoing transaction
Strategic Advice in Acquisition of Rezolute
Advised Handok/Genexine on the foregoing transaction
Equity Financing
Advised MediBeacon on the foregoing transaction
Series F Private Placement
Advised Atox Bio on the foregoing transaction
Series B Financing
Advised Eloxx on the foregoing transaction
At RMG, we strive to provide best-in-class services to our clients on their most complex strategic needs over the entire lifecycles of their businesses. With offices in New York and in Israel, our reach extends to Asia, Europe and the Americas, through our extensive network of relationships in the Life Sciences industry.
Corporate Venture Capital Management, Business Development, Project Assessment & Due Diligence Support, IPO Advice, Valuations & Fairness Opinions
READ MOREMergers and Acquisitions, Licensing, Distribution and Commercial Agreements, Divestitures and Spin-Outs
READ MORE
Corporate Strategy, Research & Development, Portfolio & Pipeline Strategy
READ MORE
Since 1992, our diverse team of accomplished professionals has worked closely with life science companies ranging from start-ups to multinationals, providing unbiased strategic and corporate finance support, based upon our comprehensive industry experience.
READ MORE